TW371628B - Composition for treating condyloma acuminata - Google Patents

Composition for treating condyloma acuminata

Info

Publication number
TW371628B
TW371628B TW086115494A TW86115494A TW371628B TW 371628 B TW371628 B TW 371628B TW 086115494 A TW086115494 A TW 086115494A TW 86115494 A TW86115494 A TW 86115494A TW 371628 B TW371628 B TW 371628B
Authority
TW
Taiwan
Prior art keywords
composition
condyloma acuminata
treating condyloma
treating
infected
Prior art date
Application number
TW086115494A
Other languages
English (en)
Inventor
shu-jun Cheng
de-chang Wang
Yukihiko Hara
Original Assignee
Mitsui Norin Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Norin Kk filed Critical Mitsui Norin Kk
Application granted granted Critical
Publication of TW371628B publication Critical patent/TW371628B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
TW086115494A 1996-11-18 1997-10-21 Composition for treating condyloma acuminata TW371628B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32119596A JP3213557B2 (ja) 1996-11-18 1996-11-18 茶カテキンを有効成分として含有する尖圭コンジローマ治療剤

Publications (1)

Publication Number Publication Date
TW371628B true TW371628B (en) 1999-10-11

Family

ID=18129859

Family Applications (1)

Application Number Title Priority Date Filing Date
TW086115494A TW371628B (en) 1996-11-18 1997-10-21 Composition for treating condyloma acuminata

Country Status (13)

Country Link
US (1) US5795911A (zh)
EP (1) EP0842660B1 (zh)
JP (1) JP3213557B2 (zh)
KR (1) KR100312252B1 (zh)
CN (1) CN1086290C (zh)
AT (1) ATE288266T1 (zh)
AU (1) AU716120B2 (zh)
CA (1) CA2221370C (zh)
DE (2) DE69732402T2 (zh)
ES (1) ES2232849T3 (zh)
FR (1) FR12C0077I2 (zh)
PT (1) PT842660E (zh)
TW (1) TW371628B (zh)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968973A (en) * 1996-11-18 1999-10-19 Cancer Institute (Hospital), Chinese Academy Of Medical Sciences Method for treating hyperplasia
US6197808B1 (en) * 1996-11-18 2001-03-06 Cancer Instititute (Hospital), Chinese Academy Of Medical Sciences Methods for treating hyperplasia
CN1063957C (zh) 1997-09-29 2001-04-04 北京华颐中药制药厂 一种金荞麦制剂的制备方法
WO1999016319A1 (en) 1997-09-29 1999-04-08 China Innovation Center For Life Science (Usa) A fagopyrum cymosum (trev.) meisn composition, method to prepare and analyze the same and uses thereof
EP0938897A1 (en) * 1997-12-26 1999-09-01 Japanese Foundation For Cancer Research Telomerase inhibitor
US6030622A (en) * 1998-06-23 2000-02-29 Shehadeh; Ahmad Abdallah Herbal extract composition and method with immune-boosting capability
EP1100496A4 (en) * 1998-07-21 2002-10-23 Univ Jefferson SMALL PROTEIN INHIBITOR MOLECULES BCL-2
KR100319973B1 (ko) * 1998-12-05 2002-04-22 이인수 녹차카테킨을 유효성분으로 하는 자궁경부 상피내종양 예방 또는 치료제 조성물
EP1390026B1 (en) 2001-05-03 2010-05-05 Cornell Research Foundation, Inc. Treatment of hpv caused diseases
DE10156794B4 (de) 2001-11-19 2006-05-18 Medigene Ag Arzneimittel zur Behandlung von Warzen
US7858662B2 (en) 2001-11-19 2010-12-28 Medigene Ag Medicament for the treatment of viral skin and tumour diseases
US7972632B2 (en) 2003-02-28 2011-07-05 Unigen Pharmaceuticals, Inc. Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
US7108868B2 (en) * 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
US8945518B2 (en) * 2002-04-30 2015-02-03 Unigen, Inc. Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
US8034387B2 (en) * 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
BRPI0309689B1 (pt) 2002-04-30 2021-06-29 Unigen, Inc Composições compreendendo uma mistura de flavonóides de anel-b-livre e flavanos e usos das mesmas
US7780992B2 (en) 2002-12-08 2010-08-24 Tareq Abduljalil Albahri Antiviral medicament
CA2521429A1 (en) * 2003-04-04 2004-10-21 Unigen Pharmaceuticals, Inc. Formulation of dual cycloxygenase (cox) and lipoxygenase (lox) inhibitors for mammal skin care
US7763588B2 (en) * 2003-06-13 2010-07-27 The Salk Institute For Biological Studies Method for increasing cognitive function and neurogenesis
WO2005020932A2 (en) * 2003-09-02 2005-03-10 Unigen Pharmaceuticals, Inc. Formulation of a mixture of free-b-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US20050079235A1 (en) * 2003-10-09 2005-04-14 Eggert Stockfleth Use of a polyphenol for the treatment of actinic keratosis
EP2292226A3 (en) * 2003-10-09 2011-08-10 MediGene AG The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin
CN100337690C (zh) * 2005-02-07 2007-09-19 上海复旦张江生物医药股份有限公司 一种评价治疗尖锐湿疣药物有效性的方法
US20070082073A1 (en) * 2005-05-18 2007-04-12 University Of South Florida Catechin Adjuvants
US8044098B2 (en) * 2005-08-02 2011-10-25 Shenghua Guangzhou Pharmaceutical Science & Technology Co., Ltd. Use of hydroxybenzoic acids and their esters and analogues for preventing or treating virus infection
KR100801891B1 (ko) 2006-11-02 2008-02-12 한상진 천연물질을 이용한 생식기 염증 예방 또는 치료용 약제학적 조성물
EP2179722A1 (en) 2008-10-24 2010-04-28 Heinrich-Pette-Institut für experimentelle Virologie und Immunologie Topical formation for preventing sexual transmission of viral infection
ES2349966B1 (es) * 2008-10-30 2011-11-18 Ignacio Umbert Millet Formulaciones topicas para el tratamiento de verrugas.
US20110218241A1 (en) * 2010-03-06 2011-09-08 Cacao Bio-Technologies, Llc Antiviral epicatechins, epicatechin oligomers, or thiolated epicatechins from theobroma cacao for treatment of genital warts
WO2012100835A1 (en) 2011-01-28 2012-08-02 Laboratorios Del Dr. Esteve, S.A. Methods and compositions for the treatment of aids
WO2014110284A1 (en) 2013-01-09 2014-07-17 Bacterin International, Inc. Bone graft substitute containing a temporary contrast agent and a method of generating such and a method of use thereof
IL254568B2 (en) * 2015-03-19 2023-11-01 Wendy Anne Epstein Catechin compounds extracted from tea leaves for the treatment of female sexual disorders
MX367243B (es) * 2016-02-04 2019-08-09 Maria Del Carmen Ramirez Olvera COMPOSICIÓN DE EXTRACTOS DE PLANTAS QUE INCREMENTAN LOS BACILOS DE DöDERLEIN, USADA PARA EL TRATAMIENTO DE ENFERMEDADES DE TRANSMISIÓN SEXUAL (ETS) Y DEL VIRUS DEL PAPILOMA HUMANO (VPH), CON EFECTO AFRODISIACO.
CN106727275A (zh) * 2016-12-15 2017-05-31 珠海聚焦先导生物研究院有限公司 一种治疗阴道炎的栓剂组合物
CN107349197A (zh) * 2017-07-13 2017-11-17 黄冈师范学院 一种儿茶素在制备治疗皮肤乳头状瘤的药物上的应用
WO2024003061A1 (en) 2022-06-30 2024-01-04 Lo.Li. Pharma S.R.L. Composition for the treatment of the human papillomavirus infection (hpv)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2128207B1 (zh) * 1971-03-11 1974-08-02 Zyma Sa
US5159069A (en) * 1988-12-20 1992-10-27 Yamanouchi Pharmaceutical Co., Ltd. Sulfated tannins and their salts
JP2727471B2 (ja) * 1989-09-14 1998-03-11 三井農林株式会社 インフルエンザウィルス感染予防剤
JPH03141220A (ja) * 1989-10-26 1991-06-17 Tsumura & Co 抗レトロウイルス剤
JP3019996B2 (ja) * 1990-03-01 2000-03-15 三井農林株式会社 白癬治療剤
US5211944A (en) * 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
DE4211238C2 (de) * 1992-04-03 1994-10-27 Edward I Budowskij Verwendung von 2',5'-Oligoadenylaten zur Behandlung von Papillomatosen
US5605929A (en) * 1992-05-27 1997-02-25 Arch Development Corp. Methods and compositions for inhibiting 5α-reductase activity
US5648377A (en) * 1993-12-21 1997-07-15 Indena S.P.A. Formulations containing carotenoids an procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals
GB2293548A (en) * 1994-09-29 1996-04-03 Joan Louise Hibberd Treatment of herpes infections
IT1275905B1 (it) * 1995-03-14 1997-10-24 Indena Spa Frazioni polifenoliche di te', loro uso e formulazioni che le contengono
US5576013A (en) * 1995-03-21 1996-11-19 Eastern Virginia Medical School Treating vascular and neoplastic tissues
JPH1036260A (ja) * 1996-07-18 1998-02-10 Mitsui Norin Kk 抗ガン剤の効力増強方法

Also Published As

Publication number Publication date
DE122009000072I1 (de) 2010-03-25
FR12C0077I2 (fr) 2013-08-16
US5795911A (en) 1998-08-18
AU716120B2 (en) 2000-02-17
KR19980042555A (ko) 1998-08-17
ATE288266T1 (de) 2005-02-15
AU4443897A (en) 1998-06-04
DE69732402T2 (de) 2006-01-19
DE69732402D1 (de) 2005-03-10
ES2232849T3 (es) 2005-06-01
CN1185947A (zh) 1998-07-01
EP0842660A1 (en) 1998-05-20
KR100312252B1 (ko) 2002-02-19
PT842660E (pt) 2005-05-31
DE122009000072I2 (de) 2011-07-21
CA2221370C (en) 2004-03-02
FR12C0077I1 (zh) 2013-02-01
JPH10147525A (ja) 1998-06-02
JP3213557B2 (ja) 2001-10-02
CA2221370A1 (en) 1998-05-18
CN1086290C (zh) 2002-06-19
EP0842660B1 (en) 2005-02-02

Similar Documents

Publication Publication Date Title
TW371628B (en) Composition for treating condyloma acuminata
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
TW200730537A (en) Methods and compositions for treating hepatitis C virus
AU7445901A (en) Pharmaceutical compositions comprising cannabidiol derivatives
AU2006252214A1 (en) Methods for treating hepatitis delta virus infection with beta-L-2'-deoxy-nucleosides
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
AU693833B2 (en) Products containing G-CSF and TNF binding protein
CA2235747A1 (en) Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for preparing drugs for treating amyotrophic lateral sclerosis
GB0020504D0 (en) Therapeutic method
EP1304108A3 (en) Anti-arrhythmic composition and methods of treatment
AU533524B2 (en) 6-substituted-11-alkylene morphanthridines
WO1999051256A3 (en) Use of l-glu-l-trp in the treatment of hiv infection
CA2289017A1 (en) The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer
AU1656997A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer
WO1999059628A3 (en) Combination therapy for the treatment of tumors
WO1997026880A3 (en) Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
WO2002076393A3 (en) Antiagionecic, antitumor, chemopreventative agents
IL129267A (en) Pharmaceutical compositions comprising histamine and/or serotonin for treatment of urinary incontinence
AU5434899A (en) Cancer treatment
HK1039935A1 (en) Use of (1r, 4s)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol in hbv
AU2396900A (en) Treatment and prevention of hiv and other viral infections
WO1999065511A3 (en) Composition and method for treatment of pseudomonas infection
UA33498A (uk) Спосіб лікування терапевтично резистентних форм шизофренії
WO2002076405A3 (en) Compositions and methods of treatment of ulcerating diseases, burns, and related conditions
HK1056117A1 (en) Treatment of hepatitis C with thymosin and pegylated interferon

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent